Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Learn why stock market indices matter for benchmark reporting, performance comparison, and portfolio context in everyday investing.
28,349 articlesSellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
IonQ is leading the field among pure-play quantum stocks in 2026, delivering a positive year-to-date return while its...
Stock crashes test nerves and portfolios. This article breaks down Warren Buffett's rule dealing with crashes and sho...
Oracle just posted best quarter in years, powered by cloud and AI demand. This article breaks down what changed, why ...
A notable fund adds Masimo stock, signaling confidence in noninvasive monitoring tech. This analysis breaks down the ...
Want anchors in a stormy market? Meet three dividend stocks never sell. These blue-chip picks blend reliable cash flo...
As homes grow pricier and college costs climb, some parents are choosing to fund down payments for Gen Z rather than ...
Unanimity in board votes can mask risk. A fresh comparison to avalanche safety training shows why dissent matters for...
A college student defies the odds by turning spare change into a growing rental portfolio. Learn the steps, the finan...
Compass International Holdings rolls out its AI-powered Home Platform across its company-owned brands, signaling a ma...
A relatable story of starting late but thinking forward. Learn how one person turned modest savings into four rental ...
As the 2027 COLA looms, savvy retirees can gain a head start by watching a handful of summer indicators. This guide b...